Co-diagnostics, inc. completes updated clade ib analysis of 2-gene mpox ruo test

Salt lake city , sept. 5, 2024 /prnewswire/ -- co-diagnostics, inc. (nasdaq-cm: codx) (the "company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the company has performed an in silico analysis of the co-dx™ logix smart® mpox (2-gene) ruo test to evaluate the possible impact of clade ib mpox on the test.
CODX Ratings Summary
CODX Quant Ranking